Every minute counts: in-hospital changes of left ventricular regional and global function in patients with ST-segment

Valeria Cammalleri1, Giorgia Marsili1, Maria Stelitano1

  • 1Department of Cardiovascular Disease.

Insights

Early percutaneous coronary intervention improves heart function in ST-segment elevation myocardial infarction patients. Shorter first medical contact-to-reperfusion times significantly enhance left ventricular ejection fraction and wall motion recovery.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring prompt treatment.
  • Left ventricular ejection fraction (LVEF) and wall motion score index (WMSI) are key indicators of cardiac function post-myocardial infarction.
  • The impact of reperfusion time on cardiac recovery in STEMI patients remains an area of active research.

Purpose of the Study:

  • To evaluate the effect of early percutaneous coronary intervention (PCI) on in-hospital LVEF and WMSI changes in STEMI patients.
  • To compare the cardiac functional recovery between STEMI patients treated with different first medical contact (FMC)-to-reperfusion times.
  • To identify predictors of significant LVEF improvement in STEMI patients undergoing PCI.

Main Methods:

  • A cohort of 324 STEMI patients undergoing PCI was divided into two groups based on FMC-to-reperfusion time: ≤90 minutes (n=173) and >90 minutes (n=151).
  • LVEF and WMSI were assessed at baseline and at discharge.
  • A subgroup analysis was conducted on patients with ≥10% LVEF improvement at discharge.

Main Results:

  • Baseline LVEF and WMSI were comparable between the two groups.
  • Patients with FMC-to-reperfusion time ≤90 minutes showed significant improvements in LVEF (P=0.001) and WMSI (P=0.009) at discharge.
  • Shorter FMC-to-reperfusion and total ischemic times were associated with a ≥10% LVEF improvement.

Conclusions:

  • Early PCI, defined by FMC-to-reperfusion time ≤90 minutes, significantly improves in-hospital left ventricular global and regional function in STEMI patients.
  • Reducing total ischemic time is crucial for optimal cardiac recovery and functional improvement post-STEMI.
  • These findings reinforce the importance of timely reperfusion strategies in managing STEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
221
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
160
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
233
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
171
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
123